Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Half Yearly Results - Advanced Enzyme Technologies

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 11:42
282.45
-3.75 (-1.31%)
VOLUME 7,267
LIVE
NSE
Dec 12, 11:42
282.80
-4.1 (-1.43%)
VOLUME 48,132
Download Annual Report PDF Format 2016

Half Yearly Results of Advanced Enzyme Technologies

------------------- in Rs. Cr. -------------------
Sep '17 Mar '17 Sep '16 Mar '16 Sep '15
Net Sales/Income from operations 94.23 95.27 78.54 72.14 67.00
Other Operating Income -- -- -- -- --
Total Income From Operations 94.23 95.27 78.54 72.14 67.00
EXPENDITURE
Consumption of Raw Materials 43.03 39.74 23.91 21.61 25.44
Purchase of Traded Goods -- -- -- -- --
Increase/Decrease in Stocks 0.45 -4.66 1.56 -4.60 -1.10
Power & Fuel -- -- -- -- --
Employees Cost 16.34 13.41 14.65 11.89 12.45
Depreciation 3.82 3.91 4.46 3.72 3.66
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 17.44 21.01 17.08 20.42 16.04
P/L Before Other Inc. , Int., Excpt. Items & Tax 13.16 21.86 16.87 19.10 10.50
Other Income 2.54 3.53 2.59 0.32 0.48
P/L Before Int., Excpt. Items & Tax 15.69 25.40 19.45 19.42 10.98
Interest 1.68 1.13 1.62 1.66 2.71
P/L Before Exceptional Items & Tax 14.02 24.26 17.84 17.76 8.27
Exceptional Items -- -- -- -- --
P/L Before Tax 14.02 24.26 17.84 17.76 8.27
Tax 3.52 3.79 4.78 3.06 1.72
P/L After Tax from Ordinary Activities 10.49 20.47 13.06 14.70 6.55
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 10.49 20.47 13.06 14.70 6.55
Equity Share Capital 22.33 22.33 22.33 21.77 21.77
Reserves Excluding Revaluation Reserves -- -- -- 153.08 --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.94 -- 5.95 -- 3.01
Diluted EPS 0.94 -- 5.95 -- 3.01
EPS After Extra Ordinary
Basic EPS 0.94 -- 5.95 -- 3.01
Diluted EPS 0.94 -- 5.95 -- 3.01
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Advanced Enzyme

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for advancedenzymetechnologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.